Latest immunotherapy news
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma
posted July 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Rituximab Noninferior to Ocrelizumab for Newly Diagnosed Relapsing MS
posted July 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Aglatimagene Besadenovec + Valacyclovir Ups DFS in Localized Prostate Cancer
posted June 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Subset of Patients With Follicular Lymphoma Can Achieve Cure With CHOP-Based Chemoimmunotherapy
posted March 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Exercise Intervention Linked to Improved Attention, Memory in Breast Cancer
Cancer Survivors Have Lower Levels of Physical Activity
Childhood Cancer Survivors Often Have Mental Distress in Adulthood
Mortality, Comorbidity Risk Increased With Generalized Pustular Psoriasis
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors